67 Publications (Page 1 of 3)
2022
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors.
King, Jennifer and Adra, Nabil
Current oncology reports, February 3, 2022. | Journal Article
 
Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?
Tachibana, IsamuMahmoud, MohammadAbedali, Zain AFlack, ChandraAdra, NabilCheng, Liang and Kaimaklitois, Hristos Z
Urologic oncology, February 8, 2022. | Journal Article
2021
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.
Taza, FadiTaza, FadiTaza, FadiTaza, FadiTaza, FadiHoller, Albert EHoller, Albert EHoller, Albert EHoller, Albert EHoller, Albert EFu, WeiFu, WeiFu, WeiFu, WeiFu, WeiWang, HaoWang, HaoWang, HaoWang, HaoWang, HaoAdra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAshkar, RyanAshkar, RyanAshkar, RyanAshkar, RyanAshkar, RyanCheng, Heather HCheng, Heather HCheng, Heather HCheng, Heather HCheng, Heather HSokolova, Alexandra OSokolova, Alexandra OSokolova, Alexandra OSokolova, Alexandra OSokolova, Alexandra OAgarwal, NeerajAgarwal, NeerajAgarwal, NeerajAgarwal, NeerajAgarwal, NeerajKessel, AdamKessel, AdamKessel, AdamKessel, AdamKessel, AdamBryce, AlanBryce, AlanBryce, AlanBryce, AlanBryce, AlanNafissi, NellieNafissi, NellieNafissi, NellieNafissi, NellieNafissi, NellieBarata, PedroBarata, PedroBarata, PedroBarata, PedroBarata, PedroSartor, A OliverSartor, A OliverSartor, A OliverSartor, A OliverSartor, A OliverBastos, DiogoBastos, DiogoBastos, DiogoBastos, DiogoBastos, DiogoSmaletz, OrenSmaletz, OrenSmaletz, OrenSmaletz, OrenSmaletz, OrenBerchuck, Jacob EBerchuck, Jacob EBerchuck, Jacob EBerchuck, Jacob EBerchuck, Jacob ETaplin, Mary-EllenTaplin, Mary-EllenTaplin, Mary-EllenTaplin, Mary-EllenTaplin, Mary-EllenAggarwal, RahulAggarwal, RahulAggarwal, RahulAggarwal, RahulAggarwal, RahulSternberg, Cora NSternberg, Cora NSternberg, Cora NSternberg, Cora NSternberg, Cora NVlachostergios, Panagiotis JVlachostergios, Panagiotis JVlachostergios, Panagiotis JVlachostergios, Panagiotis JVlachostergios, Panagiotis JAlva, Ajjai SAlva, Ajjai SAlva, Ajjai SAlva, Ajjai SAlva, Ajjai SSu, ChristopherSu, ChristopherSu, ChristopherSu, ChristopherSu, ChristopherMarshall, Catherine HMarshall, Catherine HMarshall, Catherine HMarshall, Catherine HMarshall, Catherine HAntonarakis, Emmanuel SAntonarakis, Emmanuel SAntonarakis, Emmanuel SAntonarakis, Emmanuel S and Antonarakis, Emmanuel S
JCO precision oncology, vol. 5, 2021. | Journal Article
 
Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours.
Fazal, ZeeshanFazal, ZeeshanFazal, ZeeshanSingh, RatnakarSingh, RatnakarSingh, RatnakarFang, FangFang, FangFang, FangBikorimana, EmmanuelBikorimana, EmmanuelBikorimana, EmmanuelBaldwin, HannahBaldwin, HannahBaldwin, HannahCorbet, AndreaCorbet, AndreaCorbet, AndreaTomlin, MeganTomlin, MeganTomlin, MeganYerby, CliffYerby, CliffYerby, CliffAdra, NabilAdra, NabilAdra, NabilAlbany, CostantineAlbany, CostantineAlbany, CostantineLee, SarahLee, SarahLee, SarahFreemantle, Sarah JFreemantle, Sarah JFreemantle, Sarah JNephew, Kenneth PNephew, Kenneth PNephew, Kenneth PChristensen, Brock CChristensen, Brock CChristensen, Brock CSpinella, Michael JSpinella, Michael J and Spinella, Michael J
Epigenetics, vol. 16, (no. 10), pp. 1071-1084, October 2021. | Journal Article
 
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors.
Nappi, LuciaThi, MarisaAdra, NabilHamilton, Robert JLeao, RicardoLavoie, Jean-MichelSoleimani, MaryamEigl, Bernhard JChi, KimGleave, MartinSo, AlanBlack, Peter CBell, RobertDaneshmand, SiamakCary, ClintMasterson, TimothyEinhorn, LawrenceNichols, Craig and Kollmannsberger, Christian
European urology, vol. 79, (no. 1), pp. 16-19, January 2021. | Journal Article
 
Molecular Characterization of Testicular Germ Cell Tumors Using Tissue Microdissection.
Cheng, LiangCheng, LiangCheng, LiangMann, Steven AMann, Steven AMann, Steven ALopez-Beltran, AntonioLopez-Beltran, AntonioLopez-Beltran, AntonioChovanec, MichalChovanec, MichalChovanec, MichalSantoni, MatteoSantoni, MatteoSantoni, MatteoWang, MingshengWang, MingshengWang, MingshengAlbany, CostantineAlbany, CostantineAlbany, CostantineAdra, NabilAdra, NabilAdra, NabilDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DCimadamore, AlessiaCimadamore, AlessiaCimadamore, AlessiaMontironi, RodolfoMontironi, RodolfoMontironi, RodolfoZhang, ShaoboZhang, Shaobo and Zhang, Shaobo
Methods in molecular biology (Clifton, N.J.), vol. 2195, pp. 31-47, 2021. | Journal Article
 
Pearls and perils in the management of germ cell tumors.
Wei, Cynthia XEinhorn, Lawrence H and Adra, Nabil
Current opinion in oncology, February 10, 2021. | Journal Article
 
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Calaway, Adam CKern, Sean QCrook, DavidTong, YanMasterson, Timothy AAdra, NabilEinhorn, Lawrence HFoster, Richard S and Cary, Clint
The Journal of urology, vol. 206, (no. 6), pp. 1430-1437, December 2021. | Journal Article
 
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
Ashkar, RyanAshkar, RyanAshkar, RyanAshkar, RyanFeldman, Darren RFeldman, Darren RFeldman, Darren RFeldman, Darren RAdra, NabilAdra, NabilZaid, Mohammad AbuZaid, Mohammad AZaid, Mohammad AbuZaid, Mohammad AFunt, Samuel AFunt, Samuel AFunt, Samuel AFunt, Samuel AAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KPerkins, Susan MPerkins, Susan MPerkins, Susan MPerkins, Susan MSnow, Christin ISnow, Christin ISnow, Christin ISnow, Christin ILazzara, Kayla MLazzara, Kayla MLazzara, Kayla MLazzara, Kayla MSego, Lina MSego, Lina MSego, Lina MSego, Lina MQuinn, David IQuinn, David IQuinn, David IQuinn, David IHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineCostantine, AlbanyAlbany, Costantine and Costantine, Albany
Investigational new drugs, vol. 39, (no. 6), pp. 1656-1663, December 2021. | Journal Article
 
Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter?
Speir, Ryan WBarboza, Marcelo PanizzuttiCalaway, AdamMasterson, Timothy ACary, ClintKoch, MichaelBihrle, RickCheng, LiangAdra, Nabil and Kaimakliotis, Hristos
Clinical genitourinary cancer, vol. 19, (no. 1), pp. 47-52, February 2021. | Journal Article
 
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Agrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavAbonour, RafatAbonour, RafatAbonour, RafatAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAshkar, RyanAshkar, RyanAshkar, RyanAlbany, CostantineAlbany, CostantineAlbany, CostantineHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAdra, NabilAdra, Nabil and Adra, Nabil
Cancer, July 14, 2021. | Journal Article
 
Testicular Cancer: Biology to Bedside.
King, JenniferAdra, Nabil and Einhorn, Lawrence H
Cancer research, vol. 81, (no. 21), pp. 5369-5376, November 1, 2021. | Journal Article
2020
Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
Einhorn, Lawrence HAdra, NabilHanna, Nasser and Nichols, Craig
(pp. 3073-3074). September 10, 2020
 
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
Agrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavDinh, Jr, Paul CDinh, Jr, Paul CDinh, Jr, Paul CDinh, Jr, Paul CFung, ChunkitFung, ChunkitFung, ChunkitFung, ChunkitMonahan, Patrick OMonahan, Patrick OMonahan, Patrick OMonahan, Patrick OAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KNorton, KelliNorton, KelliNorton, KelliNorton, KelliCary, ClintCary, ClintCary, ClintCary, ClintEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceFossa, Sophie DFossa, Sophie DFossa, Sophie DFossa, Sophie DAdra, NabilAdra, NabilAdra, NabilAdra, NabilTravis, Lois BTravis, Lois BTravis, Lois B and Travis, Lois B
JNCI cancer spectrum, vol. 4, (no. 2), pp. pkz079, 2020-Apr. | Journal Article
 
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer.
Albany, CostantineAlbany, CostantineFazal, ZeeshanFazal, ZeeshanSingh, RatnakarSingh, RatnakarBikorimana, EmmanuelBikorimana, EmmanuelAdra, NabilAdra, NabilHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HPerkins, Susan MPerkins, Susan MSandusky, George ESandusky, George EChristensen, Brock CChristensen, Brock CKeer, HaroldKeer, HaroldFang, FangFang, FangNephew, Kenneth PNephew, Kenneth PSpinella, Michael J and Spinella, Michael J
Cancer medicine, November 1, 2020. | Journal Article
 
A phase II study assessing the safety and efficacy of ASP1650 in male patients with incurable platinum refractory germ cell tumors
Adra, NabilAdra, NabilAdra, NabilVaughn, David JVaughn, David JVaughn, David JEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceHanna, Nasser HHanna, Nasser HHanna, Nasser HRosales, MattRosales, MattRosales, MattArozullah, AhsanArozullah, AhsanArozullah, AhsanFeldman, Darren RFeldman, Darren R and Feldman, Darren R
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. TPS424, 2020-02-20. | Journal Article
 
A phase I study of guadecitabine (SGI-110) plus cisplatin in patients with platinum refractory germ cell tumors
Albany, CostantineAlbany, CostantineAlbany, CostantineSpinella, Michael JSpinella, Michael JSpinella, Michael JAdra, NabilAdra, NabilAdra, NabilHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, LawrenceEinhorn, Lawrence and Einhorn, Lawrence
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 408, 2020-02-20. | Journal Article
 
Causes and patterns of mortality in patients with lethal germ cell tumor (GCT)
Hamid, AnisHamid, AnisFunt, Samuel AaronFunt, Samuel AaronMarkt, Sarah CMarkt, Sarah CBromberg, MariaBromberg, MariaO'Donnell, DevonO'Donnell, DevonAdra, NabilAdra, NabilTaza, FadiTaza, FadiAlbany, CostantineAlbany, CostantineKrailo, Mark DKrailo, Mark DFrazier, A. LindsayFrazier, A. LindsayEinhorn, Lawrence HEinhorn, Lawrence HFeldman, Darren RFeldman, Darren RSweeney, Christopher and Sweeney, Christopher
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 421, 2020-02-20. | Journal Article
 
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors
Antonarakis, Emmanuel SAntonarakis, Emmanuel SAntonarakis, Emmanuel SIsaacsson Velho, PedroIsaacsson Velho, PedroIsaacsson Velho, PedroFu, WeiFu, WeiFu, WeiWang, HaoWang, HaoWang, HaoAgarwal, NeerajAgarwal, NeerajAgarwal, NeerajSantos, Victor SacristanSantos, Victor SacristanSacristan Santos, VictorMaughan, Benjamin LMaughan, Benjamin LMaughan, Benjamin LPili, RobertoPili, RobertoPili, RobertoAdra, NabilAdra, NabilAdra, NabilSternberg, Cora NSternberg, Cora NSternberg, Cora NVlachostergios, Panagiotis JVlachostergios, Panagiotis JVlachostergios, Panagiotis JTagawa, Scott TTagawa, Scott TTagawa, Scott TBryce, Alan HBryce, Alan HBryce, Alan HMcNatty, Andrea LMcNatty, Andrea LMcNatty, Andrea LReichert, Zachery RReichert, Zachery RReichert, Zachery RDreicer, RobertDreicer, RobertDreicer, RobertSartor, OliverSartor, OliverSartor, OliverLotan, Tamara LLotan, Tamara LLotan, Tamara LHussain, MahaHussain, Maha and Hussain, Maha
JCO Precision Oncology, (no. 4), pp. 381, 2020-04-00. | Journal Article
 
Expression of circulating miR375 and miR371 to differentiate teratoma and viable germ cell tumor in patients with post-chemotherapy residual disease
Nappi, LuciaNappi, LuciaNappi, LuciaThi, MarisaThi, MarisaThi, MarisaAdra, NabilAdra, NabilAdra, NabilLeao, Ricardo Romao NazarioLeao, Ricardo Romao NazarioLeao, Ricardo Romao NazarioEigl, Bernhard JEigl, Bernhard JEigl, Bernhard JChi, Kim NChi, Kim NChi, Kim NGleave, MartinGleave, MartinGleave, MartinSo, AlanSo, AlanSo, AlanBlack, Peter CBlack, Peter CBlack, Peter CHamilton, Robert JamesHamilton, Robert JamesHamilton, Robert JamesDaneshmand, SiamakDaneshmand, SiamakDaneshmand, SiamakCary, ClintCary, ClintCary, ClintMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HNichols, Craig RNichols, Craig RNichols, Craig RKollmannsberger, Christian KKollmannsberger, Christian K and Kollmannsberger, Christian K
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 414, 2020-02-20. | Journal Article
 
Genomic analysis for potential targetable mutations in relapsed and refractory germ cell tumors
Kern, Sean QKern, Sean QEinhorn, Lawrence HEinhorn, Lawrence HAdra, Nabil and Adra, Nabil
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 407, 2020-02-20. | Journal Article
 
High‚Äźdose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases
Kalra, MaitriKalra, MaitriKalra, MaitriKalra, MaitriAdra, NabilAdra, NabilAdra, NabilAdra, NabilHanna, NasserHanna, NasserHanna, NasserHanna, NasserAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence H and Einhorn, Lawrence H
Cancer, vol. 126, (no. 6), pp. 1207, March 15, 2020. | Journal Article
 
Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy
Douglawi, AntoinDouglawi, AntoinDouglawi, AntoinDouglawi, AntoinCalaway, AdamCalaway, AdamCalaway, AdamCalaway, AdamTachibana, IsamuTachibana, IsamuTachibana, IsamuTachibana, IsamuPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloPanizzutti Barboza, MarceloSpeir, RyanSpeir, RyanSpeir, RyanSpeir, RyanMasterson, TimothyMasterson, TimothyMasterson, TimothyMasterson, TimothyAdra, NabilAdra, NabilAdra, NabilAdra, NabilFoster, RichardFoster, RichardFoster, RichardFoster, RichardEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceCary, ClintCary, ClintCary, Clint and Cary, Clint
The Journal of urology, pp. 101097JU0000000000000792, 2020-Jan-31. | Journal Article
 
Management of residual disease after chemotherapy in germ cell tumors
King, JenniferKing, JenniferAdra, NabilAdra, NabilEinhorn, Lawrence and Einhorn, Lawrence
Current Opinion in Oncology, vol. 32, (no. 3), pp. 255, 2020-May. | Journal Article
 
NAD(P)H: Quinone oxidoreductase (NQO1) and catalase expression in nonseminomatous germ cell tumors
Hashemi-Sadraei, NedaHashemi-Sadraei, NedaHashemi-Sadraei, NedaAdra, NabilAdra, NabilAdra, NabilKessler, Kenneth AKessler, Kenneth AKessler, Kenneth AIdrees, Muhammad TIdrees, Muhammad TIdrees, Muhammad TEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceBoothman, David ABoothman, David A and Boothman, David A
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 413, 2020-02-20. | Journal Article